Efficacy Study of "Go On" in Magnetic Resonance Imaging (MRI) Improvement in Osteoarthritis (OA) Knee
GoOn MRI
Phase 3 Study GoON and MRI Improvement in OA Knee
1 other identifier
interventional
60
1 country
1
Brief Summary
OA knee is a common degenerative diseases of the joint.
- There are many methods to treat this condition.
- Hyaluronic acid is one of the recomended treatment of OA knee.
- There is no any study on MRI change after injection hyaluronic acid.
- The Hypothesis is 25 mg of sodium hyaluronate (2.5 ml) would preserve the joint space in patient with osteoarthritis of the knee compared to placebo .
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_3
Started Jul 2008
Shorter than P25 for phase_3
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2008
CompletedFirst Submitted
Initial submission to the registry
September 9, 2008
CompletedFirst Posted
Study publicly available on registry
September 10, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2009
CompletedMay 26, 2010
July 1, 2009
1.2 years
September 9, 2008
May 25, 2010
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
MRI will be analysed with semiquantitative whole organ scoring method (WORMS) c
6 months
Secondary Outcomes (1)
WOMAC, VAS, side effects
14 months
Study Arms (2)
B
PLACEBO COMPARATOR2 ml of Normal saline intraarticular injection to the knee joint weekly for 5 weeks
A
EXPERIMENTAL2 ml of 25 mg sodium hyaluronate intraarticular injection to the knee joint weekly for 5 weeks
Interventions
25 mg sodium hyaluronate, 2 ml., intraarticular weekly for 5 weeks
Eligibility Criteria
You may qualify if:
- Subjects who are capable of giving written informed consent, which includes compliance with the requirements and restrictions listed in the consent form.
- Ambulatory non pregnant females and males 40-\<80 years of age.
- Subjects who withdraw pain medication or nutritional supplements for symptom relief for OA hand for a total of at least 30 days before screening visit 0.
- Pain at or below 40 mm on a 100 mm VAS in the index knee joints.
- A documented diagnosis of OA of the knee joint, or meeting American College of Rheumatology (ACR) clinical criteria for classification of idiopathic (primary) OA for at least 6 months prior to screening.
- Subject has been documented radiographic evidence of OA of the knees from the screening Visit radiograph of grade 2 or 3 according to Kellgren and Lawrence Radiographic Grading.
- Subject has no any contraindication for MRI
- Subject is able to understand and complete pain/function, global arthritis evaluation, and health outcome assessment.
You may not qualify if:
- Subjects with history of hypersensitivity to hyaluronate.
- Subjects with skin lesion at the knee joint.
- A history of knee surgery within 6 months prior to screening V0.
- Significant prior injury to the knee joint within 12 months prior to screening V0.
- Disease of the spine or other lower extremity joints of sufficient degree to affect the knee joint.
- Treatment with other drugs potentially affecting bone or cartilage metabolism as described below:
- chronic systematic corticosteroids
- Diacerin or glucosamine treatment within the last 12 months.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Weerachai Kosuwon
Khon Kaen, Changwat Khon Kaen, 40001, Thailand
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Weerachai Kosuwon, Professor
Faculty of Medicine, Khon Kaen University
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
September 9, 2008
First Posted
September 10, 2008
Study Start
July 1, 2008
Primary Completion
September 1, 2009
Study Completion
October 1, 2009
Last Updated
May 26, 2010
Record last verified: 2009-07